Sree Rayalaseema Hi-Strength Hypo Announces FY26 Results and Dividend Recommendation

Sree Rayalaseema Hi-Strength Hypo Limited reported a standalone net profit of ₹92.65 crore for the financial year ended March 31, 2026. Consolidated net profit stood at ₹90.14 crore for the same period.

Reader Takeaway: Stable profits driven by core chemicals, offset by exceptional investment loss.

What just happened

Sree Rayalaseema Hi-Strength Hypo Limited announced its audited financial results for the fiscal year 2026. The company posted a standalone revenue from operations of ₹666.96 crore, an increase from ₹637.82 crore in the previous year. Standalone net profit after tax was ₹92.65 crore, and consolidated net profit was ₹90.14 crore.

Why this matters

The results indicate stable performance in the company's core chemical business. The board has recommended a final dividend of ₹3 per equity share, offering a direct return to shareholders. An unmodified auditor's opinion provides assurance on the financial reporting.

The backstory

The company operates in Chemicals and Wind Energy-Power segments, with Chemicals being the primary revenue driver. In FY26, an exceptional loss of ₹13.50 crore was recorded, stemming from investments in gold and derecognition of debenture investments.

What changes now

Shareholders will await the Annual General Meeting for approval of the ₹3 per share final dividend. The company's focus remains on its chemical segment, with the exceptional loss being a one-off event.

Risks to watch

The exceptional loss from investments in gold and debentures warrants attention for potential future impacts. Diversification into non-core assets carries inherent investment risks.

Auditor Remarks

Statutory Auditors M/s. S T Mohite & Co. provided an unmodified opinion on the standalone and consolidated financial results, signifying that the financial statements fairly represent the company's position.

Context metrics (time-bound)

Standalone Revenue from Operations (FY26): ₹666.96 crore.
Standalone Net Profit After Tax (FY26): ₹92.65 crore.
Consolidated Net Profit After Tax (FY26): ₹90.14 crore.
Final Dividend Recommended: ₹3 per share (30%).
Exceptional Loss: ₹13.50 crore.

What to track next

Investors should monitor the performance of the chemical segment and management's strategy regarding investment portfolios, especially in light of the recent exceptional loss.